Longboard Pharmaceuticals Receives Rare Pediatric Designation
19 Sep 2024 //
BUSINESSWIRE
Longboard Reports Positive OLE Results For Bexicaserin In DEEs
08 Sep 2024 //
BUSINESSWIRE
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule
06 Sep 2024 //
BUSINESSWIRE
Longboard Pharmaceuticals To Host Investor Event In New York On September 16
26 Aug 2024 //
BUSINESSWIRE
Longboard`s Bexicaserin Gets Breakthrough Therapy Designation
01 Jul 2024 //
BUSINESSWIRE
Longboard Reports Q1 2024 Results, Corporate Updates
02 May 2024 //
BUSINESSWIRE